The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, North American drug delivery technologies market at a CAGR of 6.5% during the forecast period.
- Advertising -
Access sample copy@ www.reportsnreports.com/contacts/r…aspx?name=264729
The U.S. is expected to command the largest share of the North American drug delivery technologies market. The large share of the U.S. in this market can primarily be attributed to factors such as the rapidly growing geriatric population; growth in the biologics market; increasing number of regulatory approvals and new product launches; and growing number of workshops, conferences, and symposia being conducted in the country.
- Advertising -
For instance, in 2015, Aprecia Pharmaceuticals (U.S.) received FDA approval for Sprit am, the first 3D-printed prescription drug for epilepsy. In March 2016, the company introduced this product in the U.S.
market. The company’s Zip Dose (3D printing) technology enables the pill to disintegrate in the mouth with a little amount of water. Direct order to get Complete Report Copy of North American Drug Delivery Technologies Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Device), Nasal (Drop), Topical (Solid), Implantable (Active)), End User (Hospital, Home Care) - Global Forecast to 2021 at www.reportsnreports.com/purchase.aspx?name=264729
The North American drug delivery technologies market is projected to reach USD 758.7 billion by 2021 from USD 520.0 billion in 2016, at a CAGR of 6.5% during the forecast period. Major factors contributing to the growth of this market include the rising prevalence of chronic diseases, growth in the biologics market, funding initiatives for drug delivery research, and technological advancements.
However, the risk of needle stick injuries and side effects related to drugs are expected to restrain the growth of this market in the coming years.
- Drug delivery manufacturing companies
- Pharmaceutical and medical device manufacturing companies
- Healthcare institutions (hospitals and outpatient clinics)
- Drug delivery distributors and suppliers
- Research institutes
- Health insurance payers
- Market research and consulting firms
Access report at www.reportsnreports.com/contacts/d…aspx?name=264729
Each product segment has a different set of vendors. Johnson & Johnson, Inc. (U.S.), Novartis AG (Switzerland), F.
Hoffman-La-Roche Ltd. (Switzerland), Bayer AG (Germany), Pfizer, Inc. (U.S.), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), Merck & Co, Inc.
(U.S.), Sanofi (France), Antares Pharma, Inc. (U.S.), and GlaxoSmithKline Plc.
(U.K.) are some of the prominent players in the North American drug delivery technologies market.
Key Point from Table of Content
North American Drug Delivery Technologies Market, By Route of Administration
Oral Drug Delivery
Pulmonary Drug Delivery
Injectable Drug Delivery
Ocular Drug Delivery
Nasal Drug Delivery
Topical Drug Delivery
Implantable Drug Delivery
Passive Implantable Drug Delivery
Active Implantable Drug Delivery
Transmucosal Drug Delivery
Oral Transmucosal Drug Delivery
Buccal Drug Delivery
Sublingual Drug Delivery
Other Transmucosal Drug Delivery
Rectal Transmucosal Drug Delivery
Vaginal Transmucosal Drug Delivery
North American Drug Delivery Technologies Market, By End User
Ambulatory Surgical Centers/Clinics
Home Care Settings
Other End Users
Make an inquiry about this Report @ www.reportsnreports.com/contacts/i…aspx?name=264729